Executive Profile

José-Alain Sahel M.D., Ph.D. Scientific Founder, Vice Chairman of Scientific & Clinical Advisory Board and Board Observer, GenSight Biologics SA

Age	Total Calculated Compensation	This person is connected to 4 Board Members in 4 different organizations across 5 different industries. See Board Relationships
--	--

Background

Prof. José-Alain Sahel MD, PhD serves as a Director at Laboratory of Molecular and Cellular Pathobiology of the Retina, Unit 592 Inserm / Paris VI University. Prof. Sahel is Scientific Founder of GenSight Biologics SA and serves as its Board Observer. He coordinates the Paris-based Clinical Investigation Center of the National Eye Hospital at the Quinze-Vingts. He established and heads the National Reference Center for Retinal Dystrophies. He serves as Chairman of the ... Department of Ophthalmology IV at the Quinze-Vingts National Eye Hospital (Paris). Prof. Sahel co-founded Fovea Pharmaceuticals, SA and served as its Chief Scientific Advisor. He serves as Vice Chairman of Scientific & Clinical Advisory Board at GenSight Biologics SA. Prof. Sahel is Professor of Ophthalmology; Faculté de Médecine Saint-Antoine at Université Pierre et Marie Curie/Paris VI and Professor of Biomedical Sciences (Cumberlege Chair) at Institute of Ophthalmology-University College London. Prof. Sahel serves as Chairman of Scientific Advisory Board of Fovea Pharmaceuticals, SA. He serves as a Member of Scientific Advisory Board of Neurotech Pharmaceuticals, Inc. (also known as Neurotech SA) and Cellectis. He served as a Director of Fovea Pharmaceuticals, SA. He served as a Member of Scientific Advisory Board at Novagali Pharma SA. He is Chairman of the Department of Ophthalmology IV at the Rothschild Ophthalmology Foundation. He was Coordinator of the European Framework Program 6 integrated project EVI-Genoret. He is Director of Institut de la Vision (INSERM Unit UMR_S968 UPMC/ CNRS 7210. He was elected in 2007 as a Member of the Académie des Sciences-Institut de France and of the Academia Ophthalmologia Internationalis. He was Chair of the Neuroprotection Committee of the SAB of the Foundation Fighting Blindness. He is the author of over 180 peer-reviewed publications. He is conducting pioneering research into the understanding of the pathological mechanisms involved in retinal cell degeneration. He is the 2006 recipient of the Alcon Research Institute Award for Excellence in Vision Research. Prof. Sahel has received Awards from the US Foundation Fighting Blindness and the French Académie des Sciences, for his work on retinitis pigmentosa.

Corporate Headquarters Institut de la Vision Paris, Ile-de-France 75012 France Phone: 33 1 44 16 42 42 Fax: 33 1 44 16 42 40 Board Members Memberships Co-Founder and Chairman of Scientific Advisory Board Fovea Pharmaceuticals SA Education There is no Education data available. Other Affiliations Neurotech Pharmaceuticals, Inc. Novagali Pharma S.A. Cellectis Fovea Pharmaceuticals SA

Annual Compensation There is no Annual Compensation data available. Stocks Options There is no Stock Options data available. Total Compensation There is no Total Compensation data available.

COMPETITOR COMPENSATION

There is no Competitor Compensation data available.